Exposure #1 · 21 CFR 111.75(a)(1)(i) & 111.75(a)(2)(ii)
CRITICAL (Top #1 Cited 483 Observation)
Your procedure permits releasing incoming dietary ingredients based on a supplier's Certificate of Analysis (COA) or periodic organoleptic checks without performing at least one verified identity test (e.g., FTIR, HPLC, HPTLC) on 100% of incoming dietary ingredient lots, and without documented 3-lot vendor COA qualification.
Real Verbatim FDA Form 483 Language (34% of Dietary Supplement Form 483s):
"Your firm failed to conduct at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient prior to use in manufacturing a dietary supplement, as required by 21 CFR 111.75(a)(1)(i). Specifically, your SOP states QA releases raw botanical and vitamin lots upon visual review of the vendor's COA."
Priority CAPA Fix & Required SOP Language:
Mandate 100% identity testing (FTIR/HPLC/specific identity assay) on every incoming dietary ingredient lot before quarantine release. For non-dietary components, document a formal supplier qualification protocol (audit + 3 consecutive full confirmatory lab panels + annual re-qualification) before relying on any vendor COA.
Exposure #2 · 21 CFR 111.205(a) & 21 CFR 111.260(e)
HIGH (Cited in 28% of Supplement & OTC 483s)
Using uncontrolled Excel formulation sheets or single-initial sign-offs violates 21 CFR 111.205 and 111.260. Inspectors require version-controlled Master Manufacturing Records (MMRs) for each unique formulation and batch size, plus BPRs capturing component lot numbers, scale weight printouts, dual verification, and yield reconciliation.
Real Verbatim FDA Form 483 Language (28% of Supplement & OTC Form 483s):
"Your batch production records failed to include complete information relating to the production and control of each batch (21 CFR 111.260). Specifically, batch sheets printed from Excel lacked raw component lot traceability, scale calibration IDs, theoretical vs. actual yield reconciliation, and second-person verification of active additions."
Priority CAPA Fix & Required SOP Language:
Replace ad-hoc Excel sheets with Quality-approved Master Manufacturing Records (MMRs) per SKU/batch size, and add component lot fields, scale weight printouts, dual-operator verification, and +/- 2% yield reconciliation to every BPR.
Exposure #3 · 21 CFR 111.75(c) & 21 CFR 211.166
HIGH (Cited in 25% of Supplement & Drug 483s)
Assigning a 24-month expiration date based on 'industry standard' or shipping product while microbial plates are still incubating is an immediate Form 483 observation (and frequent Warning Letter trigger). Any expiration date on a label must be supported by data, and finished batches must meet potency and microbiological specifications prior to release.
Real Verbatim FDA Form 483 Language (25% of Supplement & Drug Form 483s):
"You established a two-year expiration date on your finished products without data supporting that the product meets established specifications through the expiration period, and released batches to distribution prior to completion of USP microbial limits testing (21 CFR 111.75(c) / 21 CFR 211.165)."
Priority CAPA Fix & Required SOP Language:
Hold all finished batches in Quarantine until active assay, USP <2021>/<2022> microbial limits, and heavy metal CofAs are signed off by QA, and enroll representative lots in ICH Q1A accelerated (40°C/75% RH) and real-time stability.
Exposure #4 · 21 CFR 111.27(d), 21 CFR 117.35 & 21 CFR 211.67
MODERATE-HIGH (Cited in 22% of Inspections)
Visual-only cleaning inspections, rinsing without validated detergent concentration/contact time, monthly-only purified water checks, or deferred warehouse dock door seal repairs expose the facility to sanitation and cross-contamination citations.
Real Verbatim FDA Form 483 Language (22% of Food, Supplement & Drug Form 483s):
"You failed to maintain equipment, utensils, and contact surfaces in a clean and sanitized condition (21 CFR 111.27(d) / 21 CFR 117.35). Specifically, cleaning logs lacked lot-to-lot traceability and ATP/allergen swab verification, and a gap was observed along the bottom sweep of the Warehouse Zone C overhead dock door."
Priority CAPA Fix & Required SOP Language:
Implement batch-linked equipment cleaning logs with ATP/allergen swabbing and QA line-clearance signatures, daily TOC/conductivity water checks, and immediate 48-hour maintenance work orders for any perimeter pest/door seal gap.
Exposure #5 · 21 CFR 111.553, FD&C Act Sec. 605 (MoCRA) & 21 CFR 820.198
MODERATE-HIGH (Cited in 19% of Inspections)
Logging customer complaints in Zendesk for refunds without Quality Unit review, root-cause investigation of related batches, or Serious Adverse Event (SAE) reporting procedures violates 21 CFR 111.553 / 820.198 / MoCRA Sec. 605.
Real Verbatim FDA Form 483 Language (19% of Supplement, Cosmetic & Device Form 483s):
"Your Quality Unit failed to review and approve all product complaints to determine whether the complaint involves a possible failure of a dietary supplement to meet any of its specifications (21 CFR 111.553), and product labeling omitted required domestic phone/address or electronic contact instructions for Serious Adverse Event reporting."
Priority CAPA Fix & Required SOP Language:
Route 100% of health, quality, or packaging complaints to QA within 24 hours, require documented root-cause CAPA and retention-sample inspection, and include a dedicated domestic phone/address for adverse event reporting on all labels.